Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.

Published 4 weeks ago Negative
Biotech Stocks Have Struggled Since 2021. Why They’re Coming Back.
Auto

Related Stocks

ABT.US Abbott Laborato...
Too many questionable start-ups went public during the pandemic, when the sector was hot. Now, after over four years of pain, the weak have failed, rates are falling, and M&A looks to be on the upswing.

Continue Reading

View Comments

More News

Synopsys, Inc. (SNPS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - RGRD Law

19 minutes ago Negative

My wife and I were doing OK on $79K until we had a baby. Now we’re $20K in debt and dying to get back on track. But how?

1 hour ago Negative

This Congresswoman is Buying Adobe (ADBE)

1 hour ago Negative

Vertreter der thailändischen Berufsbildung besuchen das Guangxi Financial Vocational College, um gemeinsam einen neuen Entwurf für die Berufsbildung zu erörtern

1 hour ago Negative

UPS, FedEx ground MD-11 cargo planes on recommendations of Boeing

1 hour ago Negative